Lupin Pharmaceuticals, INC.

Generic pharmaceutical manufacturer

Based in MD

🤖

AI Overview

With $200K in lobbying spend across 9 quarterly filings, Lupin Pharmaceuticals, INC is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2019 to 2020.

$200K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2019	$80K
2020	$120K

Issues Lobbied

Health Issues Budget/Appropriations Defense Trade

Lobbying Firms

Government Counsel, LLC

Lobbyists

Henry Menn

Government Agencies Targeted

These are the government entities that Lupin Pharmaceuticals, INC. disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Defense, Trade

electronic drug labeling, drug take back program and USPTO inter partes review procedure.

President's Budget For A Better America (FY20202) relating to the Department of Health and Human Services generic drug exclusivity proposal.

H.R. 938-The Blocking Act; H.R. 1499-Protecting Consumer Access to Generic Drugs Act of 2019.

H.R. 938-The Blocking Act; H.R. 987 - Strengthening Health Care and Lowering Prescription Drug Costs;S. 1895-Lower Health Care Costs Ac.

H.R. 938-The Blocking Act; H.R. 987-Strengthening Health Care and Lowering Prescription Drug Costs; S. 1895-Lower Health Care Costs Ac (Sec.205).